UniProt ID | ZN813_HUMAN | |
---|---|---|
UniProt AC | Q6ZN06 | |
Protein Name | Zinc finger protein 813 | |
Gene Name | ZNF813 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 617 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be involved in transcriptional regulation.. | |
Protein Sequence | MALPQGLLTFRDVAIEFSQEEWKCLDPAQRTLYRDVMLENYRNLVSLDISSKCMMKEFSSTAQGNREVIHTGTLQRHESHHTGDFRFQEIDKDIHNLEFQWQEDERNSHEAPMTEIKKLTGSADRYDQRHAGNKPIKDQLGSSFHSHLPELHMFQTQGKIGNQVEKSINDASSISTSQRISCRPKTHISNNYGNNFRNSSLLTQKQEVHMREKSFQCNESGKAFNYSSLLRKHQIIHLGEKQYKCDVCGKVFNRKRNLVCHRRCHTGEKPYRCNECGKTFSQTYSLTCHRRLHTGEKPYKCEECDKAFSFKSNLKRHRRIHAGEKPYKCNECGKTFSQTSSLTCHRRLHTGEKPFKCNECGKTFSRKSSLTCHHRLHTGEKPYKCNECGKTFSQELTLKCHRRLHTGEKPYKCNECGKVFNKKANLARHHRLHSGEKPYKCTECVKTFSRNSALVIHKAIHIGEKRYKCNECGKTFSRISALVIHTAIHTGEKPYKCNECGKGFNRKTHLACHHRLHTGEKPYKCNECGKVFNRKTHLAHHHRLHTGDKPYKCNECGKVFNQKAHLARHHRLHTGEKPYKCNECGKVFNQKANLARHHRLHTGEKPYKFNECGKAFN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Phosphorylation | RDVAIEFSQEEWKCL HHHHHCCCHHHHHHC | 24.72 | 27251275 | |
23 | Ubiquitination | EFSQEEWKCLDPAQR CCCHHHHHHCCHHHH | 28.35 | - | |
41 | Phosphorylation | RDVMLENYRNLVSLD HHHHHHHHHHHEECC | 7.48 | 22210691 | |
46 | Phosphorylation | ENYRNLVSLDISSKC HHHHHHEECCCCCCH | 24.40 | 22210691 | |
56 | Ubiquitination | ISSKCMMKEFSSTAQ CCCCHHHHHHHHHHC | 28.82 | - | |
60 | Phosphorylation | CMMKEFSSTAQGNRE HHHHHHHHHHCCCCE | 32.84 | 30631047 | |
134 | Ubiquitination | DQRHAGNKPIKDQLG HHCCCCCCCHHHHHH | 47.40 | - | |
175 | Phosphorylation | INDASSISTSQRISC HHCCHHCCHHHCCCC | 24.77 | - | |
176 | Phosphorylation | NDASSISTSQRISCR HCCHHCCHHHCCCCC | 27.49 | - | |
177 | Phosphorylation | DASSISTSQRISCRP CCHHCCHHHCCCCCC | 15.63 | - | |
227 | Phosphorylation | SGKAFNYSSLLRKHQ CCCCCCHHHHHHHHC | 18.66 | 26434776 | |
228 | Phosphorylation | GKAFNYSSLLRKHQI CCCCCHHHHHHHHCE | 22.51 | 24719451 | |
287 | Phosphorylation | FSQTYSLTCHRRLHT HHEEEEEEEECCCCC | 10.58 | - | |
294 | Phosphorylation | TCHRRLHTGEKPYKC EEECCCCCCCCCCCC | 52.18 | 27422710 | |
297 | Sumoylation | RRLHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
297 | Ubiquitination | RRLHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | 21890473 | |
297 | Sumoylation | RRLHTGEKPYKCEEC CCCCCCCCCCCCCCC | 55.80 | - | |
300 | Sumoylation | HTGEKPYKCEECDKA CCCCCCCCCCCCCCC | 43.63 | - | |
300 | Sumoylation | HTGEKPYKCEECDKA CCCCCCCCCCCCCCC | 43.63 | - | |
309 | Phosphorylation | EECDKAFSFKSNLKR CCCCCCCCCHHHHHH | 36.30 | 24719451 | |
328 | Sumoylation | HAGEKPYKCNECGKT CCCCCCEECCCCCCC | 38.83 | - | |
328 | Sumoylation | HAGEKPYKCNECGKT CCCCCCEECCCCCCC | 38.83 | - | |
335 | Phosphorylation | KCNECGKTFSQTSSL ECCCCCCCCCCCCCC | 17.50 | - | |
339 | Phosphorylation | CGKTFSQTSSLTCHR CCCCCCCCCCCEECC | 21.05 | - | |
340 | Phosphorylation | GKTFSQTSSLTCHRR CCCCCCCCCCEECCE | 18.73 | 27251275 | |
341 | Phosphorylation | KTFSQTSSLTCHRRL CCCCCCCCCEECCEE | 30.96 | 27251275 | |
343 | Phosphorylation | FSQTSSLTCHRRLHT CCCCCCCEECCEECC | 14.28 | - | |
350 | Phosphorylation | TCHRRLHTGEKPFKC EECCEECCCCCCEEC | 52.18 | 18669648 | |
353 | Sumoylation | RRLHTGEKPFKCNEC CEECCCCCCEECCCC | 58.04 | - | |
353 | Sumoylation | RRLHTGEKPFKCNEC CEECCCCCCEECCCC | 58.04 | - | |
362 | Ubiquitination | FKCNECGKTFSRKSS EECCCCCCCCCCCCC | 59.04 | - | |
378 | Phosphorylation | TCHHRLHTGEKPYKC EECCCCCCCCCCEEC | 52.18 | 27422710 | |
381 | Sumoylation | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
381 | Ubiquitination | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | 21890473 | |
381 | Sumoylation | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
383 | Phosphorylation | LHTGEKPYKCNECGK CCCCCCCEECCCCCC | 38.96 | - | |
384 | Sumoylation | HTGEKPYKCNECGKT CCCCCCEECCCCCCC | 38.83 | - | |
384 | Sumoylation | HTGEKPYKCNECGKT CCCCCCEECCCCCCC | 38.83 | - | |
384 | Ubiquitination | HTGEKPYKCNECGKT CCCCCCEECCCCCCC | 38.83 | - | |
406 | Phosphorylation | KCHRRLHTGEKPYKC HHHHCCCCCCCCEEC | 52.18 | 27422710 | |
409 | Sumoylation | RRLHTGEKPYKCNEC HCCCCCCCCEECCCC | 55.80 | - | |
409 | Ubiquitination | RRLHTGEKPYKCNEC HCCCCCCCCEECCCC | 55.80 | 21890473 | |
409 | Sumoylation | RRLHTGEKPYKCNEC HCCCCCCCCEECCCC | 55.80 | - | |
411 | Phosphorylation | LHTGEKPYKCNECGK CCCCCCCEECCCCHH | 38.96 | - | |
412 | Sumoylation | HTGEKPYKCNECGKV CCCCCCEECCCCHHC | 38.83 | - | |
412 | Ubiquitination | HTGEKPYKCNECGKV CCCCCCEECCCCHHC | 38.83 | - | |
412 | Sumoylation | HTGEKPYKCNECGKV CCCCCCEECCCCHHC | 38.83 | - | |
422 | Acetylation | ECGKVFNKKANLARH CCHHCCCHHHHHHHH | 41.62 | 20167786 | |
434 | Phosphorylation | ARHHRLHSGEKPYKC HHHHCCCCCCCCCCC | 53.92 | 26425664 | |
465 | Acetylation | KAIHIGEKRYKCNEC EEEHHCCCCEECCCC | 56.68 | 13467601 | |
474 | Ubiquitination | YKCNECGKTFSRISA EECCCCCCCHHHHHH | 59.04 | - | |
490 | Phosphorylation | VIHTAIHTGEKPYKC HHHHHHHCCCCCEEC | 40.71 | 29496963 | |
493 | Ubiquitination | TAIHTGEKPYKCNEC HHHHCCCCCEECCCC | 55.80 | - | |
493 | Sumoylation | TAIHTGEKPYKCNEC HHHHCCCCCEECCCC | 55.80 | - | |
493 | Sumoylation | TAIHTGEKPYKCNEC HHHHCCCCCEECCCC | 55.80 | - | |
495 | Phosphorylation | IHTGEKPYKCNECGK HHCCCCCEECCCCCC | 38.96 | 18767875 | |
496 | Sumoylation | HTGEKPYKCNECGKG HCCCCCEECCCCCCC | 38.83 | - | |
496 | Sumoylation | HTGEKPYKCNECGKG HCCCCCEECCCCCCC | 38.83 | - | |
518 | Phosphorylation | ACHHRLHTGEKPYKC HHCCCCCCCCCCEEC | 52.18 | 27422710 | |
521 | Sumoylation | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
521 | Ubiquitination | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | 21890473 | |
521 | Sumoylation | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
523 | Phosphorylation | LHTGEKPYKCNECGK CCCCCCCEECCCCCC | 38.96 | - | |
524 | Sumoylation | HTGEKPYKCNECGKV CCCCCCEECCCCCCC | 38.83 | - | |
524 | Ubiquitination | HTGEKPYKCNECGKV CCCCCCEECCCCCCC | 38.83 | - | |
524 | Sumoylation | HTGEKPYKCNECGKV CCCCCCEECCCCCCC | 38.83 | - | |
546 | Phosphorylation | AHHHRLHTGDKPYKC HHCCCCCCCCCCEEC | 52.23 | 24719451 | |
549 | Acetylation | HRLHTGDKPYKCNEC CCCCCCCCCEECCCH | 52.14 | 25953088 | |
552 | Sumoylation | HTGDKPYKCNECGKV CCCCCCEECCCHHHH | 38.83 | - | |
552 | Sumoylation | HTGDKPYKCNECGKV CCCCCCEECCCHHHH | 38.83 | - | |
574 | Phosphorylation | ARHHRLHTGEKPYKC HHHCCCCCCCCCEEC | 52.18 | 27422710 | |
577 | Sumoylation | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
577 | Ubiquitination | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | 21890473 | |
577 | Sumoylation | HRLHTGEKPYKCNEC CCCCCCCCCEECCCC | 55.80 | - | |
579 | Phosphorylation | LHTGEKPYKCNECGK CCCCCCCEECCCCHH | 38.96 | - | |
580 | Sumoylation | HTGEKPYKCNECGKV CCCCCCEECCCCHHH | 38.83 | - | |
580 | Ubiquitination | HTGEKPYKCNECGKV CCCCCCEECCCCHHH | 38.83 | - | |
580 | Sumoylation | HTGEKPYKCNECGKV CCCCCCEECCCCHHH | 38.83 | - | |
602 | Phosphorylation | ARHHRLHTGEKPYKF HHHCCCCCCCCCCCC | 52.18 | 27422710 | |
605 | Sumoylation | HRLHTGEKPYKFNEC CCCCCCCCCCCCCCC | 55.80 | - | |
605 | Ubiquitination | HRLHTGEKPYKFNEC CCCCCCCCCCCCCCC | 55.80 | 21890473 | |
605 | Sumoylation | HRLHTGEKPYKFNEC CCCCCCCCCCCCCCC | 55.80 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN813_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN813_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN813_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ZN813_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...